BioCentury
ARTICLE | Top Story

FDA approves QLT's Visudyne

April 12, 2000 7:00 AM UTC

The FDA granted marketing approval for Visudyne verteporfin photodynamic therapy to treat wet age-related macular degeneration (AMD). Visudyne was developed by QLT PhotoTherapeutics (TSE:QLT; QLTI) an...